Clicky

Novartis Ag Basl(NVSEF) News

Date Title
Jul 28 HS market forecast to reach $7.8bn across 7MM by 2034
Jul 28 Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts?
Jul 28 AAV for the Hereditary Retinal Diseases Market Competitive Landscape Report 2025 | Novartis, MeiraGTx, 4D Molecular Therapeutics, and Beacon Therapeutics Lead the Charge in Innovative Therapies
Jul 25 Myeloproliferative Disorder Treatment Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Novartis, Incyte, Bristol Myers Squibb, CTI BioPharma, GSK, PharmaEssentia
Jul 25 Post-Operative Nausea and Vomiting Market Report 2025: Surge in Surgical Procedures Fuels $2.97 Billion Growth in PONV Market by 2029
Jul 24 Incyte Gears Up to Report Q2 Earnings: Is a Beat in the Cards?
Jul 24 Fibroblast Growth Factors (FGFs) Global Market Report 2025-2029 & 2034 | Regenerative Medicine Demand and Biotech Advancements Fueling Expansion
Jul 24 Here's Why Novartis (NVS) is a Strong Value Stock
Jul 24 Arvinas, Inc. (ARVN): A Bull Case Theory
Jul 24 How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Jul 24 Novartis to pay Matchpoint up to $1 billion to develop anti-inflammatory therapies
Jul 24 Matchpoint Therapeutics Announces Exclusive Option and License Agreement with Novartis to Develop Oral Inhibitors for Multiple Inflammatory Diseases
Jul 24 Behcet's Disease Market Research Report 2025-2035 | Key Trends, Regulatory Framework, Epidemiology, Clinical Trial Analysis, Market Dynamics
Jul 24 Tinnitus Market Analysis and Forecast Report 2025-2035 | Pharma Giants Drive Treatment Advances with Off-Label CNS Drugs Amid Intensifying Market Competition
Jul 24 Benign Breast Disease and Early Breast Cancer Market Analysis Report 2025-2035 | Key Emerging Trends That are Reshaping the Landscape of Diagnosis, Treatment, and Patient Care
Jul 24 CAR T-Cell Therapy Market Trends and Forecasts, 2021-2024 & 2025-2033 | Focus on Yescarta, Tecartus, Kymriah, Breyanzi, Abecma, Carvykti, and Carteyva
Jul 24 Novartis' (VTX:NOVN) Performance Is Even Better Than Its Earnings Suggest
Jul 23 Rheumatoid Arthritis Therapeutics Market Forecast Report 2025-2034 | Rising Preference for Combination Therapies, and Entry of Generic Drugs Supports Expansion
Jul 23 Epilepsy Drugs Market Growth Analysis, Forecast Trends and Outlook Report 2025-2034 | Demand for Generic Epilepsy Drugs Rises as Patent Expirations Fuel Market Growth
Jul 22 Analysis Group Co-Authors Examine the Advancements in and Application of Health Economics and Outcomes Research to the Evaluation of Cell and Gene Therapies for Rare Diseases